Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Fibrogen Inc CS (FGEN)

Fibrogen Inc CS (FGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
FibroGen Appoints David DeLucia as Chief Financial Officer

FibroGen appoints David DeLucia as Chief Financial Officer, effective December 16, 2024, following Juan Graham's departure.Quiver AI SummaryFibroGen, Inc. has appointed David DeLucia as the new Chief Financial...

FGEN : 0.4000 (+13.09%)
FibroGen Appoints David DeLucia as Chief Financial Officer

FGEN : 0.4000 (+13.09%)
FibroGen: Q3 Earnings Snapshot

FibroGen: Q3 Earnings Snapshot

FGEN : 0.4000 (+13.09%)
FibroGen Reports Third Quarter 2024 Financial Results

FGEN : 0.4000 (+13.09%)
FibroGen to Report Third Quarter 2024 Financial Results

FGEN : 0.4000 (+13.09%)
FibroGen: Q2 Earnings Snapshot

FibroGen: Q2 Earnings Snapshot

FGEN : 0.4000 (+13.09%)
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments

/CNW/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may...

RHHBY : 34.5000 (+0.76%)
ONCY : 0.8310 (-6.36%)
VSTM : 4.19 (-5.63%)
CADL : 8.75 (-12.15%)
FGEN : 0.4000 (+13.09%)
REGN : 701.85 (-0.90%)
ONC.TO : 1.19 (-9.16%)
The Fight Against Pancreatic Cancer: Biotech Firms Develop New Solutions for Rising Gen X Cases

USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may be experiencing larger per-capita...

ONCY : 0.8310 (-6.36%)
ONC.TO : 1.19 (-9.16%)
RHHBY : 34.5000 (+0.76%)
VSTM : 4.19 (-5.63%)
CADL : 8.75 (-12.15%)
FGEN : 0.4000 (+13.09%)
REGN : 701.85 (-0.90%)
Stock Index Futures Slip on Growth Fears, U.S. JOLTs Report in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.36%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.34% this morning after weak manufacturing data raised concerns about the U.S. economic health,...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
PARA : 10.66 (+0.76%)
NVDA : 134.70 (+3.08%)
BA : 177.35 (+0.18%)
SAIC : 111.42 (+1.19%)
FANG : 154.94 (+1.23%)
DVN : 30.77 (+0.82%)
CRWD : 362.29 (+3.21%)
FERG : 178.17 (+2.44%)
PVH : 107.45 (+3.68%)
HPE : 21.61 (+4.09%)
Biotech Innovations Drive Pancreatic Cancer Treatment: Market Expected to Reach $7.4 Billion by 2032

USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by focusing on earlier detection. According to Johns Hopkins...

ONCY : 0.8310 (-6.36%)
ONC.TO : 1.19 (-9.16%)
VSTM : 4.19 (-5.63%)
CTMX : 1.0900 (-0.91%)
BNTX : 113.08 (+1.56%)
FGEN : 0.4000 (+13.09%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar